DIN 02554283 — OTULFI 45 MG
OTULFI is a solution of Ustekinumab marketed by FRESENIUS KABI CANADA LTD. The full Ustekinumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02554283
- Brand name
- OTULFI
- Active ingredient
- Ustekinumab
- Strength
- 45 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- FRESENIUS KABI CANADA LTD
- Health Canada status
- MARKETED
- Drug class
- Selective immunomodulating agent (interleukin-12/23 antagonist)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Ustekinumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02537303 | FINLIUS | 45 MG | SOLUTION | JANSSEN INC | MARKETED |
| 02537257 | FINLIUS | 90 MG | SOLUTION | JANSSEN INC | MARKETED |
| 02537311 | FINLIUS I.V. | 5 MG | SOLUTION | JANSSEN INC | MARKETED |
| 02543036 | JAMTEKI | 45 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02543044 | JAMTEKI | 90 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02553120 | JAMTEKI I.V. | 5 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02554291 | OTULFI | 90 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02554305 | OTULFI I.V. | 5 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02550539 | PYZCHIVA | 45 MG | SOLUTION | SAMSUNG BIOEPIS CO., LTD | MARKETED |
| 02550547 | PYZCHIVA | 90 MG | SOLUTION | SAMSUNG BIOEPIS CO., LTD | MARKETED |
| 02550520 | PYZCHIVA I.V. | 5 MG | SOLUTION | SAMSUNG BIOEPIS CO., LTD | MARKETED |
| 02320673 | STELARA | 45 MG | SOLUTION | JANSSEN INC | MARKETED |
| 02320681 | STELARA | 90 MG | SOLUTION | JANSSEN INC | MARKETED |
| 02459671 | STELARA I.V. | 5 MG | SOLUTION | JANSSEN INC | MARKETED |
| 02550245 | STEQEYMA | 45 MG | SOLUTION | CELLTRION INC. | MARKETED |
| 02550253 | STEQEYMA | 90 MG | SOLUTION | CELLTRION INC. | MARKETED |
| 02550261 | STEQEYMA IV | 5 MG | SOLUTION | CELLTRION INC. | MARKETED |
| 02544180 | WEZLANA | 45 MG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02544202 | WEZLANA | 45 MG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02553317 | WEZLANA | 45 MG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02544199 | WEZLANA | 90 MG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02553309 | WEZLANA | 90 MG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02544210 | WEZLANA I.V. | 5 MG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02562081 | YESINTEK | 45 MG | SOLUTION | BIOCON BIOLOGICS CANADA INC | MARKETED |
| 02562103 | YESINTEK | 90 MG | SOLUTION | BIOCON BIOLOGICS CANADA INC | MARKETED |
| 02562111 | YESINTEK I.V. | 5 MG | SOLUTION | BIOCON BIOLOGICS CANADA INC | MARKETED |